ChronoScale Corp (CHRN) director awarded 200,000 restricted shares vesting over two years

Rhea-AI Filing Summary

CLANCY WILLIAM M reported acquisition or exercise transactions in this Form 4 filing.

ChronoScale Corp director William M. Clancy received a grant of 200,000 restricted shares of common stock as equity compensation. The shares were awarded at no cash purchase price and are held directly.

According to the vesting schedule, 100,000 restricted shares will vest on the one-year anniversary of the May 14, 2026 grant date, and another 100,000 will vest on the two-year anniversary. Vesting requires his continuous service with the company through each vesting date, with potential adjustments or accelerated vesting under certain conditions. After this grant, Clancy owns 200,000 shares of ChronoScale common stock directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider CLANCY WILLIAM M

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	200,000	$0.00	--

Holdings After Transaction: Common Stock — 200,000 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Restricted stock grant: 200,000 shares First vesting tranche: 100,000 shares Second vesting tranche: 100,000 shares +2 more

5 metrics

Restricted stock grant 200,000 shares Grant of ChronoScale common stock on May 14, 2026

First vesting tranche 100,000 shares Vest on one-year anniversary of May 14, 2026 grant date

Second vesting tranche 100,000 shares Vest on two-year anniversary of May 14, 2026 grant date

Transaction price per share $0.0000 per share Indicates equity compensation grant, not cash purchase

Shares owned after transaction 200,000 shares Total ChronoScale common shares held directly following grant

Key Terms

restricted shares, Grant Date, continuous service, accelerated vesting

4 terms

restricted shares financial

"Represents restricted shares of common stock of ChronoScale Corporation"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

Grant Date financial

"granted on May 14, 2026 (the "Grant Date") which vest as follows"

The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.

continuous service financial

"subject to the Reporting Person's continuous service with the Issuer"

accelerated vesting financial

"subject to adjustment or accelerated vesting upon certain conditions"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CLANCY WILLIAM M

(Last) (First) (Middle)

3811 TURTLE CREEK BOULEVARD

SUITE 2100

(Street)

DALLAS TEXAS 75219

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ChronoScale Corp [ CHRN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/14/2026		A		200,000(1)	A	$0	200,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted shares of common stock of ChronoScale Corporation (the "Issuer") granted on May 14, 2026 (the "Grant Date") which vest as follows: (i) 100,000 restricted shares will vest on the one-year anniversary of the Grant Date; and (ii) 100,000 restricted shares will vest on the two-year anniversary of the Grant Date, subject to the Reporting Person's continuous service with the Issuer through the applicable vesting date and subject to adjustment or accelerated vesting upon certain conditions.

	/s/ Jerome Wong as Attorney-in-Fact	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did ChronoScale Corp (CHRN) report for William M. Clancy?

ChronoScale reported that director William M. Clancy received 200,000 restricted shares of common stock as an equity grant. These were awarded at no cash purchase price and are subject to a time-based vesting schedule over two years from the May 14, 2026 grant date.

How many ChronoScale (CHRN) shares did William M. Clancy acquire in this Form 4 filing?

William M. Clancy acquired 200,000 restricted shares of ChronoScale common stock in this transaction. All 200,000 are held directly, with 100,000 scheduled to vest after one year and the remaining 100,000 after two years from the May 14, 2026 grant date.

What is the vesting schedule for William M. Clancy’s CHRN restricted stock grant?

The 200,000 restricted shares vest in two equal tranches. 100,000 restricted shares vest on the one-year anniversary of the May 14, 2026 grant date, and 100,000 vest on the two-year anniversary, contingent on his continuous service and subject to potential adjustment or accelerated vesting conditions.

Did William M. Clancy pay cash for the ChronoScale (CHRN) shares reported on Form 4?

No, the reported transaction is a grant of restricted shares with a per-share transaction price of 0.0000. This indicates an equity compensation award rather than an open-market purchase, so Clancy did not pay cash to acquire these 200,000 ChronoScale common shares.

How many ChronoScale (CHRN) shares does William M. Clancy hold after this grant?

Following this equity grant, William M. Clancy holds 200,000 shares of ChronoScale common stock directly. These consist of restricted shares subject to the two-year vesting schedule described, with vesting dependent on his continuous service with the company through each vesting date.

Are there any conditions attached to William M. Clancy’s CHRN restricted stock grant?

Yes, vesting of the 200,000 restricted shares requires Clancy’s continuous service with ChronoScale through each vesting date. The footnote also notes that the award is subject to adjustment or accelerated vesting upon certain conditions, though those specific conditions are not detailed here.